Novartis AG
CKIT antibody drug conjugates
Last updated:
Abstract:
The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
Status:
Grant
Type:
Utility
Filling date:
27 Jul 2015
Issue date:
29 Sep 2020